The chemokine MCP-1 (CCL2) also figures among the top-scoring analytes that can predict noncirrhotic NAFLD versus healthy (Figure 2); it is significantly increased in the “simple steatosis” group compared to the healthy controls (Figure 1). The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatotic liver disease.